Literature DB >> 26093050

Vitamin D receptor gene polymorphisms in Alzheimer's disease patients.

Łukasz Łaczmański1, Marta Jakubik2, Grażyna Bednarek-Tupikowska3, Joanna Rymaszewska2, Natalia Słoka3, Felicja Lwow4.   

Abstract

THE AIM: The aim of this study was to determine whether polymorphisms of the VDR gene may increase the risk of Alzheimer disease (AD) development in Lower Silesian patients in comparison with other populations.
MATERIAL AND METHODS: 108 AD patients (aged 73.7±8.6) vs 77 healthy volunteers (aged 64.5±7.8) in the Lower Silesian population were studied. We investigated the frequency of the VDR polymorphisms rs731236 (TaqI), rs7975232 (ApaI), rs10735810 (FokI) and rs1544410 (BsmI) in the AD group vs the healthy group. Afterwards, MEDLINE and ResearchGate were studied to compare our investigation with other populations, due to the relatively small group size in our study.
RESULTS: We did not observe any significant differences in frequency of genotypes of rs731236 (TaqI), rs10735810 (FokI) or rs1544410 (BsmI) VDR polymorphisms between the two Lower Silesian groups. Frequency of allele A of ApaI in the control group was significantly higher vs AD patients (p<0.0177) in the Lower Silesian population. Furthermore the difference in the occurrence of allele t in TaqI and allele A in ApaI between AD patients vs the control group was significant (respectively p<0.0056, p<0.0140) in British Europeans. This observation may suggest that allele "a" of the ApaI polymorphism is a risk allele in AD Lower Silesian patients. We compared our results with those obtained for the population of British Europeans. In multivariate stepwise regression, allele "A" of ApaI was associated with 30% lower risk of AD (OR=0.70, p=0.0009) in total treated Polish and British populations. We did not observe similar results in Turkish and Iranian populations.
CONCLUSION: Our data suggest that the allele "A" VDR genotype of ApaI reduces AD risk, probably depending on ethnic origin and climatic conditions.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AD; VDR polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26093050     DOI: 10.1016/j.exger.2015.06.012

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  14 in total

1.  Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Authors:  Erdinç Dursun; Esin Candaş; Selma Yılmazer; Duygu Gezen-Ak
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

2.  Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson's disease.

Authors:  Nicole M Gatto; Kimberly C Paul; Janet S Sinsheimer; Jeff M Bronstein; Yvette Bordelon; Rebecca Rausch; Beate Ritz
Journal:  J Neurol Sci       Date:  2016-09-11       Impact factor: 3.181

3.  Vitamin D Receptor and Megalin Gene Polymorphisms Are Associated with Longitudinal Cognitive Change among African-American Urban Adults.

Authors:  May A Beydoun; Salman M Tajuddin; Greg A Dore; Jose-Atilio Canas; Hind A Beydoun; Michele K Evans; Alan B Zonderman
Journal:  J Nutr       Date:  2017-04-26       Impact factor: 4.798

Review 4.  Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters.

Authors:  Keumhan Noh; Edwin C Y Chow; Holly P Quach; Geny M M Groothuis; Rommel G Tirona; K Sandy Pang
Journal:  AAPS J       Date:  2022-06-01       Impact factor: 3.603

5.  Impact of vitamin D receptor polymorphisms in centenarians.

Authors:  Cristina Gussago; Beatrice Arosio; Franca Rosa Guerini; Evelyn Ferri; Andrea Saul Costa; Martina Casati; Elisa Mariadele Bollini; Francesco Ronchetti; Elena Colombo; Giuseppina Bernardelli; Mario Clerici; Daniela Mari
Journal:  Endocrine       Date:  2016-03-08       Impact factor: 3.633

6.  Evidence for the Importance of Vitamin D Status in Neurologic Conditions.

Authors:  Anusha K Yeshokumar; Deanna Saylor; Michael D Kornberg; Ellen M Mowry
Journal:  Curr Treat Options Neurol       Date:  2015-12       Impact factor: 3.598

Review 7.  Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails.

Authors:  Véréna Landel; Cédric Annweiler; Pascal Millet; Maria Morello; François Féron
Journal:  J Alzheimers Dis       Date:  2016-05-11       Impact factor: 4.472

Review 8.  Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.

Authors:  Priscilla Koduah; Friedemann Paul; Jan-Markus Dörr
Journal:  EPMA J       Date:  2017-11-15       Impact factor: 6.543

9.  Vitamin D Receptor Gene Polymorphisms and Risk of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Nanyang Liu; Tingting Zhang; Lina Ma; Wei Wei; Zehui Li; Xuefan Jiang; Jiahui Sun; Hui Pei; Hao Li
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

10.  Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease.

Authors:  Véréna Landel; Pascal Millet; Kévin Baranger; Béatrice Loriod; François Féron
Journal:  Mol Neurodegener       Date:  2016-03-01       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.